☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Centessa
PharmaShots Weekly Snapshots (February 21-25, 2022)
February 25, 2022
Centessa Reports the First Patient Dosing in the P-III (ACTION) Study of Lixivaptan for Autosomal Dominant Polycystic Kidney Disea...
February 25, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.